Filograna, Roberta http://orcid.org/0000-0002-6581-9426
Gerlach, Jule
Choi, Hae-Na
Rigoni, Giovanni
Barbaro, Michela http://orcid.org/0000-0002-7598-9330
Oscarson, Mikael
Lee, Seungmin
Tiklova, Katarina
Ringnér, Markus http://orcid.org/0000-0001-5469-8940
Koolmeister, Camilla
Wibom, Rolf
Riggare, Sara http://orcid.org/0000-0002-2256-7310
Nennesmo, Inger
Perlmann, Thomas
Wredenberg, Anna
Wedell, Anna
Motori, Elisa
Svenningsson, Per http://orcid.org/0000-0001-6727-3802
Larsson, Nils-Göran http://orcid.org/0000-0001-5100-996X
Article History
Received: 12 September 2023
Accepted: 11 April 2024
First Online: 29 April 2024
Competing interests
: N-G.L. is a scientific founder and owns stock in <i>Pretzel Therapeutics Inc</i> and declares no non-financial competing interests. R.F. and C.K. act as a paid consultant for <i>Pretzel Therapeutics Inc</i>. All other authors declare non. financial competing interests.